ERBB2 and breast carcinoma: FABP7 facilitates a glycolytic phenotype and storage of lipid droplets, thereby enabling HER2-positive breast cancer cells to adapt more effectively to the relatively hypoxic and nutrient-restricted microenvironment of the brain.227